Keith L. Ligon

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary Table S1 from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study

  2026-06-17

• Supplementary Table S4 from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study

  2026-06-17

• Supplementary Table S5 from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study

  2026-06-17

• Supplementary Table S2 from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study

  2026-06-17

• Supplementary Figure S2 from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study

  2026-06-17

• Supplementary Figure S1 from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study

  2026-06-17

• Supplementary Table S3 from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study

  2026-06-17

• Data from Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study

  2026-06-17

• Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma

  Nature Cancer · 2026-06-12

• Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data

  Journal of Clinical Oncology · 2026-05-22

• Abstract 4326: Dissecting oncolytic virus anti-virus vs anti-tumor immunity in glioma: Insights from a patient derived organoid model

  Cancer Research · 2026-04-03

• Abstract 2178: Integrating patient-derived tumor models into translational oncology and drug discovery.

  Cancer Research · 2026-04-03

• Inertial sensing of water content in tumor spheroids

  Science Advances · 2026-04-03

• Abstract 816: Spatial metabolic gradients drive epigenetic reprogramming in human glioblastoma.

  Cancer Research · 2026-04-03

• Abstract 2512: A real time imaging based functional precision medicine (FPM) assay for glioblastoma

  Cancer Research · 2026-04-03

• Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas

  Cell Reports · 2026-02-26

• Supplementary Figure S6 from <i>(R)</i>-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in <i>IDH</i>-Mutant Cancers

  2025-12-11

• Supplementary Figure S2 from <i>(R)</i>-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in <i>IDH</i>-Mutant Cancers

  2025-12-11

• Supplementary Figure S10 from <i>(R)</i>-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in <i>IDH</i>-Mutant Cancers

  2025-12-11

• Supplementary Table S6 from <i>(R)</i>-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in <i>IDH</i>-Mutant Cancers

  2025-12-11